76 related articles for article (PubMed ID: 3446738)
1. [The clinical usefulness of serum SCC antigen level determinations in patients with malignant tumor].
Mitsuhashi N; Nagai T; Okazaki A; Hayakawa K; Katoh S; Sugiyama S; Nakayama Y; Niibe H
Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2182-90. PubMed ID: 3446738
[No Abstract] [Full Text] [Related]
2. [Clinical significance of serum levels of SCC antigen in cancers of the oral cavity].
Yoshida H; Kinehara M; Sato K
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3595-601. PubMed ID: 2817910
[TBL] [Abstract][Full Text] [Related]
3. [A clinical study on CA 15-3, CEA, SCC-Ag in patients with squamous cell carcinoma of the lung].
Moriya H; Suzuki S; Aizumi J; Kimura K; Urabe S; Higuci Y; Hoshi K
Rinsho Hoshasen; 1989 Jan; 34(1):63-6. PubMed ID: 2724610
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
[TBL] [Abstract][Full Text] [Related]
5. [Studies on antigen associated with human squamous cell carcinoma (SCC antigen) in patients with esophageal carcinoma].
Hirata S; Yamazaki K; Yokoyama Y; Ueda M; Kubo Y; Samejima N
Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):267-72. PubMed ID: 2747608
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
[TBL] [Abstract][Full Text] [Related]
7. [The clinical usefulness of SCC antigen for diagnosis of recurrent cervical squamous cancer].
Umezawa S; Takeshima N; Shimizu Y; Hasumi K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):165-8. PubMed ID: 7706858
[No Abstract] [Full Text] [Related]
8. [Clinical and fundamental study of a squamous cell carcinoma related antigen (SCC-RA) for esophageal squamous cell carcinoma].
Ikeda K
Nihon Geka Gakkai Zasshi; 1991 Apr; 92(4):387-96. PubMed ID: 1870566
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of serum squamous cell carcinoma antigen for early detection of squamous cell carcinoma arising in mature cystic teratoma of the ovary.
Miyazaki K; Tokunaga T; Katabuchi H; Ohba T; Tashiro H; Okamura H
Obstet Gynecol; 1991 Sep; 78(3 Pt 2):562-6. PubMed ID: 1870825
[TBL] [Abstract][Full Text] [Related]
11. [Squamous cell carcinoma antigen for monitoring patients with head neoplasm].
Adamiak G; Ligeziński A; Jurkiewicz D; Hermanowski M; Konieczna M
Pol Merkur Lekarski; 1999 Nov; 7(41):221-3. PubMed ID: 10680455
[TBL] [Abstract][Full Text] [Related]
12. [Squamous cell carcinoma antigen levels in patients with laryngeal cancer].
Polberg K; Stepulak A; Stryjecka-Zimmer M; Kupisz K; Zawiślak J
Pol Merkur Lekarski; 2005 Sep; 19(111):375-6. PubMed ID: 16358876
[TBL] [Abstract][Full Text] [Related]
13. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
[TBL] [Abstract][Full Text] [Related]
14. [The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck].
Zöller J; Fiehn W; Mende U; Hotz G
Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(4):254-9. PubMed ID: 2134649
[TBL] [Abstract][Full Text] [Related]
15. [SCC antigen: a sensitive and specific tumor marker for squamous cell carcinoma?].
Fischbach W; Rink C
Dtsch Med Wochenschr; 1988 Feb; 113(8):289-93. PubMed ID: 2449322
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G
Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of SCC antigen assay as a tumor marker].
Kato H
Nihon Rinsho; 1990 Feb; 48 Suppl():1057-9. PubMed ID: 2192106
[No Abstract] [Full Text] [Related]
18. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
Zeng L
Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
[TBL] [Abstract][Full Text] [Related]
19. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
[TBL] [Abstract][Full Text] [Related]
20. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
